Lonapegsomatropin
ATC H01AC09 · 3 markets · 25 records
Lonapegsomatropin
Forms
US 14 records · 14 strengths
- 13.3 mginjectionSkytrofa
- 11 mginjectionSkytrofa
- 9.1 mginjectionSkytrofa
- 7.6 mginjectionSkytrofa
- 6.3 mginjectionSkytrofa
- 5.2 mginjectionSkytrofa
- 4.3 mginjectionSkytrofa
- 3.6 mginjectionSkytrofa
- 3 mginjectionSkytrofa
- 2.5 mginjectionSkytrofa
- 2.1 mginjectionSkytrofa
- 1.8 mginjectionSkytrofa
Other strengths: 1.4 mg injection、0.7 mg injection
AU 10 records · 3 strengths
- 22 mg/mLinjectionSKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridge
- 11 mg/mLinjectionSKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridge
Records without a stated strength · 1 Skytrofa
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Skytrofa
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.